Browse the corpus

REFERENCES Adams JA, Albers G, Alberts JS, et al, “Update to the AHA/ASA Recommendations for the Prevention of Stroke on Patients With Stroke and Transient Ischemic Attack,” Stroke , 2008, 39(5):1647-52. [PubMed 18322260 ] Amarenco P, Bogousslavsky J, Callahan A 3rd, et al, “High-Dose Atorvastatin After Stroke or Transient Ischemic Attack. The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators,” N Engl J Med , 2006, 355(6):549-59. [PubMed 16899775 ] American Diabetes Association, “Standards of Medical Care in Diabetes Mellitus -- 2012,” Diabetes Care , 2012, 35(Suppl ):11-63. [PubMed 22187469 ] Anderson JL, Adams CD, Antman EM, et al, "2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines," Circulation , 2011, 123(18):e426-579. [PubMed 21444888 ] Antman EM, Anbe DT, Armstrong PW, et al. “ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction),” J Am Coll Cardiol , 2004, 44(3):671-719. [PubMed 15358045 ] Antman EM, Hand M, Armstrong PW, et al, “2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines,” J Am Coll Cardiol , 2008, 51(2):210-49. [PubMed 18191746 ] Berglund L, Brunzell JD, Goldberg AC, et al, “Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline,” J Clin Endocrinol Metab , 2012, 97(9):2969-89. [PubMed 22962670 ] Briguori C, Visconti G, Focaccio A, et al, “Novel Approaches for Preventing or Limiting Events (Naples) II trial: Impact of a Single High Loading Dose of Atorvastatin on Periprocedural Myocardial Infarction,” J Am Coll Cardiol , 2009, 54(23):2157-63. [PubMed 19664895 ]

Berglund L, Brunzell JD, Goldberg AC, et al, “Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline,” J Clin Endocrinol Metab , 2012, 97(9):2969-89. [PubMed 22962670 ] Briguori C, Visconti G, Focaccio A, et al, “Novel Approaches for Preventing or Limiting Events (Naples) II trial: Impact of a Single High Loading Dose of Atorvastatin on Periprocedural Myocardial Infarction,” J Am Coll Cardiol , 2009, 54(23):2157-63. [PubMed 19664895 ] Cannon CP, Braunwald E, McCabe CH, et al, “Intensive Versus Moderate Lipid Lowering With Statins After Acute Coronary Syndromes. Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 Investigators,” N Engl J Med , 2004, 350(15):1495-504. [PubMed 15007110 ] Castro C and Gourley M, "Diagnosis and Treatment of Inflammatory Myopathy: Issues and Management," Ther Adv Musculoskelet Dis , 2012, 4(2):111-20. [PubMed 22870499 ] Davidson MH and Robinson JG, “Safety of Aggressive Lipid Management,” J Am Coll Cardiol , 2007, 49(17):1753-62. [PubMed 17466224 ] de Denus S and Spinler SA, “Early Statin Therapy for Acute Coronary Syndromes,” Ann Pharmacother , 2002, 36(11):1749-58. [PubMed 12398573 ] de Lemos JA, Blazing MA, Wiviott SD, et al, “Early Intensive vs a Delayed Conservative Simvastatin Strategy in Patients with Acute Coronary Syndromes,” JAMA , 2004, 292(11):1307-16. [PubMed 15337732 ] Di Sciascio G, Patti G, Pasceri V, et al, “Efficacy of Atorvastatin Reload in Patients on Chronic Statin Therapy Undergoing Percutaneous Coronary Intervention: Results of the ARMYDA-RECAPTURE (Atorvastatin for Reduction of Myocardial Damage During Angioplasty) Randomized Trial,” J Am Coll Cardiol , 2009, 54(6):558-65. [PubMed 19643320 ] “Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III),” JAMA , 2001, 285(19):2486-97. [PubMed 11368702 ] Fernandez AB, Karas RH, Alsheikh-Ali AA, et al, “Statins and Interstitial Lung Disease: A Systematic Review of the Literature and of Food and Drug Administration Adverse Event Reports,” Chest , 2008, 134(4):824-30. [PubMed 18689579 ]

“Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III),” JAMA , 2001, 285(19):2486-97. [PubMed 11368702 ] Fernandez AB, Karas RH, Alsheikh-Ali AA, et al, “Statins and Interstitial Lung Disease: A Systematic Review of the Literature and of Food and Drug Administration Adverse Event Reports,” Chest , 2008, 134(4):824-30. [PubMed 18689579 ] Fihn SD, Gardin JM, Abrams J, et al, “2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons,” Circulation , 2012, 126(25):3097-137. [PubMed 23166211 ] Fleisher LA, Beckman JA, Brown KA, et al, “2009 ACCF/AHA Focused Update on Perioperative Beta Blockade Incorporated Into the ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery. A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines,” J Am Coll Cardiol , 2009, 54(22):e13-118. [PubMed 19926002 ] Fonarow GC, French WJ, Parsons LS, et al, “Use of Lipid-Lowering Medications at Discharge in Patients With Acute Myocardial Infarction: Data From the National Registry of Myocardial Infarction 3,” Circulation , 2001, 103(1):38-44. [PubMed 11136683 ] Grundy SM, Cleeman JI, Merz CN, et al, “Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines,” J Am Coll Cardiol , 2004, 44(3):720-32. [PubMed 15358046 ] Heeschen C, Hamm CW, Laufs U, et al, “Withdrawal of Statins Increases Event Rates in Patients With Acute Coronary Syndromes,” Circulation , 2002, 105(12):1446-52. [PubMed 11914253 ] Hillis LD, Smith PK, Anderson JL, et al, “2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines,” Circulation , 2011, 124(23):2610-42. [PubMed 22064600 ]

Heeschen C, Hamm CW, Laufs U, et al, “Withdrawal of Statins Increases Event Rates in Patients With Acute Coronary Syndromes,” Circulation , 2002, 105(12):1446-52. [PubMed 11914253 ] Hillis LD, Smith PK, Anderson JL, et al, “2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines,” Circulation , 2011, 124(23):2610-42. [PubMed 22064600 ] Koren MJ, Smith DG, Hunninghake DB, et al, “The Cost of Reaching National Cholesterol Education Program (NCEP) Goals in Hypercholesterolaemic Patients. A Comparison of Atorvastatin, Simvastatin, Lovastatin, and Fluvastatin,” Pharmacoeconomics , 1998, 14(1):59-70. [PubMed 10182195 ] LaRosa JC, Grundy SM, Waters DD, et al, “Intensive Lipid Lowering With Atorvastatin in Patients With Stable Coronary Disease,” N Engl J Med , 2005, 352(14):1425-35. [PubMed 15755765 ] LeManach Y, Godet G, Coriat P, et al, “The Impact of Postoperative Discontinuation or Continuation of Chronic Statin Therapy on Cardiac Outcome After Major Vascular Surgery,” Anesth Analg , 2007, 104(6):1326-33. [PubMed 17513620 ] Levine GN, Bates ER, Blankenship JC, et al, “2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions,” Circulation , 2011, 124(23):e574-651. [PubMed 22064601 ] McPherson R, Frohlich J, Fodor G, et al, “Canadian Cardiovascular Society Position Statement--Recommendations for the Diagnosis and Treatment of Dyslipidemia and Prevention of Cardiovascular Disease,” Can J Cardiol , 2006, 22(11):913-27; published erratum appears in Can J Cardiol , 2006, 22(12):1077. [PubMed 16971976 ] “MRC/BHF Heart Protection Study of Cholesterol Lowering With Simvastatin in 20,536 High-Risk Individuals: A Randomised Placebo-Controlled Trial. Heart Protection Study Collaborative Group,” Lancet , 2002, 360(9326):7-22. [PubMed 12114036 ] O'Gara PT, Kushner FG, Ascheim DD, et al, "2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines," Circulation , 2012, 127(4):e362-425. [PubMed 3247304 ]

“MRC/BHF Heart Protection Study of Cholesterol Lowering With Simvastatin in 20,536 High-Risk Individuals: A Randomised Placebo-Controlled Trial. Heart Protection Study Collaborative Group,” Lancet , 2002, 360(9326):7-22. [PubMed 12114036 ] O'Gara PT, Kushner FG, Ascheim DD, et al, "2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines," Circulation , 2012, 127(4):e362-425. [PubMed 3247304 ] Pasceri V, Patti G, Nusca A, et al, “Randomized Trial of Atorvastatin for Reduction of Myocardial Damage During Coronary Intervention: Results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) Study,” Circulation , 2004, 110(6):674-8. [PubMed 15277322 ] Pasternak RC, Smith SC Jr, Bairey-Merz CN, et al, “ACC/AHA/NHLBI Clinical Advisory on the Use and Safety of Statins,” Stroke , 2002, 33(9):2337-41. Available at file://stroke.ahajournals.org/cgi/content/short/33/9/2337 [PubMed 12215610 ] Patti G, Pasceri V, Colonna G, et al, “Atorvastatin Pretreatment Improves Outcomes in Patients With Acute Coronary Syndromes Undergoing Early Percutaneous Coronary Intervention: Results of the ARMYDA-ACS Randomized Trial,” J Am Coll Cardiol , 2007, 49(12):1272-8. [PubMed 17394957 ] Pearson TA, Mensah GA, Alexander RW, et al, “Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: A Statement for Healthcare Professionals From the Centers for Disease Control and Prevention and the American Heart Association,” Circulation , 2003, 107(3):499-511. [PubMed 12551878 ] Pederson TR, Faergerman O, Kastelein JJ, et al, “High-Dose Atorvastatin vs Usual-Dose Simvastatin for Secondary Prevention After Myocardial Infarction: The IDEAL Study: A Randomized Controlled Trial,” JAMA , 2005, 294(19):2437-45. [PubMed 16287954 ] Pitt B, Waters D, Brown WV, et al, “Aggressive Lipid-Lowering Therapy Compared With Angioplasty in Stable Coronary Artery Disease. Atorvastatin Versus Revascularization Treatment Investigators,” N Engl J Med , 1999, 341(2):70-6. [PubMed 10395630 ] Poldermans D, Bax JJ, Kertai MD, et al, “Statins Are Associated With a Reduced Incidence of Perioperative Mortality in Patients Undergoing Major Noncardiac Vascular Surgery,” Circulation , 2003, 107(14):1848-51. [PubMed 12695283 ]

Pitt B, Waters D, Brown WV, et al, “Aggressive Lipid-Lowering Therapy Compared With Angioplasty in Stable Coronary Artery Disease. Atorvastatin Versus Revascularization Treatment Investigators,” N Engl J Med , 1999, 341(2):70-6. [PubMed 10395630 ] Poldermans D, Bax JJ, Kertai MD, et al, “Statins Are Associated With a Reduced Incidence of Perioperative Mortality in Patients Undergoing Major Noncardiac Vascular Surgery,” Circulation , 2003, 107(14):1848-51. [PubMed 12695283 ] Ridker PM, Danielson E, Fonseca FAH, et al, “Rosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein,” N Engl J Med , 2008, 359(21):2195-207. [PubMed 18997196 ] Schwartz GG, Olsson AG, Ezekowitz MD, et al, “Effects of Atorvastatin on Early Recurrent Ischemic Events in Acute Coronary Syndromes: The MIRACL Study: A Randomized Controlled Trial,” JAMA , 2001, 285(13):1711-8. [PubMed 11277825 ] Sever PS, Dahlof B, Poulter NR, et al, “Prevention of Coronary and Stroke Events With Atorvastatin in Hypertensive Patients Who Have Average or Lower-Than-Average Cholesterol Concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial - Lipid-Lowering Arm (ASCOT-LLA): A Multicentre Randomised Controlled Trial,” Lancet , 2003, 361(9364):1149-58. [PubMed 12686036 ] Shepherd J, Cobbe SM, Ford I, et al, “Prevention of Coronary Heart Disease With Pravastatin in Men With Hypercholesterolemia. West of Scotland Coronary Prevention Study Group,” N Engl J Med , 1995, 333(20):1301-7. [PubMed 7566020 ] Smith SC Jr, Benjamin EJ, Bonow RO, et al, “AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update: A Guideline From the American Heart Association and American College of Cardiology Foundation,” Circulation , 2011, 124(22):2458-73. [PubMed 22052934 ] Waters DD, LaRosa JC, Barter P, et al, “Effects Of High-Dose Atorvastatin On Cerebrovascular Events In Patients With Stable Coronary Disease In The TNT (Treating To New Targets) Study,” J Am Coll Cardiol , 2006, 48(9):1793-9. [PubMed 17084252 ] Topic 8949 Version 56.0 © 2013 UpToDate, Inc. All rights reserved. | Subscription and License Agreement | Release: 21.4 - C21.36 Licensed to: Southeast Alabama Med Ctr | Support Tag: [1004-122.72.76.133-3453397B85-S244013.14]